Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Downgrades Clarus Therapeutics Hldgs to Hold

Needham Downgrades Clarus Therapeutics Hldgs to Hold

Needham analyst Serge Belanger downgrades Clarus Therapeutics Hldgs (NASDAQ:CRXT) from Buy to Hold.

August 23, 2022

1 minute read

Needham analyst Serge Belanger downgrades Clarus Therapeutics Hldgs (NASDAQ:CRXT) from Buy to Hold.

Expert Ratings for Okta

October 6, 9:46 AM

Okta (NASDAQ:OKTA) has observed the following analyst ratings within the last quarter:

November 10, 12:17 PM

GrowGeneration Corp. (NASDAQ: GRWG) acquired St. Louis Hydroponic Company, a hydroponic retail store in St. Louis, Missouri.

May 22, 5:00 PM

Within the last quarter, Progressive (NYSE:PGR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

October 20, 10:22 AM

Truist Securities analyst Brandon King maintains F N B (NYSE:FNB) with a Buy and raises the price target from $14 to $16.